Slonin Jonathan's Form 4 filing
Pacira BioSciences, Inc. (PCRX) · filed Jan 6, 2025
- Accession no.
- 0001396814-25-000007
- Filed
- Jan 6, 2025
- Trade date
- Jan 2-6, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $16.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Slonin JonathanCIK 0001875723 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2025 | Common Stock | FTax withholdingDisposed | −371 | $18.33 | −$6,800.43 | 94,322.51 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −879 | $18.40 | −$16,173.6 | 93,443.51 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.